Case Report: Successful treatment of new onset plaque psoriasis with secukinumab in a peritoneal dialysis patient

• by Junyan Fang, Ruolin Li, Yingxin Xie, Yingli Liu

• July 8, 2026

Effectiveness and safety of switching biologics after secukinumab treatment failure in moderate-to-severe plaque psoriasis: a retrospective cohort study

• by Zhongyu Zhang, Bin Zhang, Yating Wen, Qian Hu, Wenjun Jiang, Jia Zhuo, Guangying Luo, Yuyi Wang

• July 6, 2026

Real-life experience of tildrakizumab 200 mg in complex psoriatic patients: a case series

• by Giulia Odorici, Cinzia Buligan, Carolina Fantini, Lucia Mantovani, Giulia Rech, Lidia Sacchelli

• July 14, 2026

Psoriasis–AD Switching May Mimic Treatment Failure

Recognizing sustained switches between the two diseases can prevent premature discontinuation of effective biologics and point toward Janus kinase inhibitors, a 148-patient cohort suggests.

• by Andrea Surnit

• June 15, 2026

• 4 min